Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.
2.

Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England.

Saxena S, Atchison C, Cecil E, Sharland M, Koshy E, Bottle A.

J Infect. 2015 Oct;71(4):428-36. doi: 10.1016/j.jinf.2015.06.011. Epub 2015 Jul 6.

PMID:
26159503
3.

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR.

Lancet. 2007 Apr 7;369(9568):1179-86.

PMID:
17416262
4.

Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine.

Strachan RE, Snelling TL, Jaffé A.

Bull World Health Organ. 2013 Mar 1;91(3):167-73. doi: 10.2471/BLT.12.109231. Epub 2012 Dec 11. Erratum in: Bull World Health Organ. 2013 May 1;91(5):388.

5.

Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay.

Pírez MC, Algorta G, Chamorro F, Romero C, Varela A, Cedres A, Giachetto G, Montano A.

Pediatr Infect Dis J. 2014 Jul;33(7):753-9. doi: 10.1097/INF.0000000000000294.

PMID:
24492286
6.

Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.

Li ST, Tancredi DJ.

Pediatrics. 2010 Jan;125(1):26-33. doi: 10.1542/peds.2009-0184. Epub 2009 Nov 30. Erratum in: Pediatrics. 2010 Feb;125(2):415.

PMID:
19948570
7.

Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.

Wiese AD, Griffin MR, Zhu Y, Mitchel EF Jr, Grijalva CG.

Vaccine. 2016 Dec 7;34(50):6243-6249. doi: 10.1016/j.vaccine.2016.10.062. Epub 2016 Nov 7.

8.

Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.

Grijalva CG, Nuorti JP, Zhu Y, Griffin MR.

Clin Infect Dis. 2010 Mar 15;50(6):805-13. doi: 10.1086/650573.

9.

Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.

Scotta MC, Veras TN, Klein PC, Tronco V, Polack FP, Mattiello R, Pitrez PM, Jones MH, Stein RT, Pinto LA.

Vaccine. 2014 Jul 31;32(35):4495-9. doi: 10.1016/j.vaccine.2014.06.042. Epub 2014 Jun 21.

PMID:
24958703
10.

Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.

Lindstrand A, Bennet R, Galanis I, Blennow M, Ask LS, Dennison SH, Rinder MR, Eriksson M, Henriques-Normark B, Ortqvist A, Alfvén T.

Pediatrics. 2014 Dec;134(6):e1528-36. doi: 10.1542/peds.2013-4177. Epub 2014 Nov 10.

11.

Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.

Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO.

Pediatr Infect Dis J. 2006 Mar;25(3):250-4.

PMID:
16511389
12.

Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.

Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, García-de-Miguel MJ, Hernández-Sampelayo T, Otheo E, Méndez C; Heracles Study Group.

Pediatr Infect Dis J. 2013 Jun;32(6):656-61. doi: 10.1097/INF.0b013e31827e8594.

PMID:
23249906
13.

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis.

Simonsen L, Taylor RJ, Schuck-Paim C, Lustig R, Haber M, Klugman KP.

Lancet Respir Med. 2014 May;2(5):387-94. doi: 10.1016/S2213-2600(14)70032-3. Epub 2014 Mar 10.

PMID:
24815804
14.

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.

Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E.

Lancet Infect Dis. 2015 May;15(5):535-43. doi: 10.1016/S1473-3099(15)70044-7. Epub 2015 Mar 20. Erratum in: Lancet Infect Dis. 2015 Jun;15(6):629.

15.

Trends in pneumonia and empyema in Scottish children in the past 25 years.

Roxburgh CS, Youngson GG, Townend JA, Turner SW.

Arch Dis Child. 2008 Apr;93(4):316-8. Epub 2007 Nov 15.

PMID:
18006562
16.

Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia.

Elemraid MA, Rushton SP, Shirley MD, Thomas MF, Spencer DA, Eastham KM, Hampton F, Gorton R, Pollard K, Gennery AR, Clark JE; North East of England Paediatric Respiratory Infection Study Group.

Epidemiol Infect. 2013 Aug;141(8):1697-704. doi: 10.1017/S0950268812002257. Epub 2012 Oct 19.

17.

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.

Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG.

N Engl J Med. 2013 Jul 11;369(2):155-63. doi: 10.1056/NEJMoa1209165.

18.

Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.

Martin NG, Sadarangani M, Pollard AJ, Goldacre MJ.

Lancet Infect Dis. 2014 May;14(5):397-405. doi: 10.1016/S1473-3099(14)70027-1. Epub 2014 Mar 14.

PMID:
24631222
19.

Has the incidence of empyema in Scottish children continued to increase beyond 2005?

Nath S, Thomas M, Spencer D, Turner S.

Arch Dis Child. 2015 Mar;100(3):255-8. doi: 10.1136/archdischild-2014-306525. Epub 2014 Sep 26.

PMID:
25260518
20.

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.

Lepoutre A, Varon E, Georges S, Dorléans F, Janoir C, Gutmann L, Lévy-Bruhl D; Microbiologists of Epibac; ORP Networks.

Vaccine. 2015 Jan 3;33(2):359-66. doi: 10.1016/j.vaccine.2014.11.011. Epub 2014 Nov 20.

PMID:
25448105

Supplemental Content

Support Center